Signal transducer and activator of transcription 3
Showing 1 - 25 of >10,000
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
Not yet recruiting
- Pyoderma Gangrenosum
- +2 more
- immunohistochemical methods
- (no location specified)
Mar 21, 2022
Lymphadenitis, Tuberculous, Immune Defect Trial in Surabaya (Immuno-histochemical staining)
Completed
- Lymphadenitis, Tuberculous
- Immune Defect
- Immuno-histochemical staining
-
Surabaya, East Java, IndonesiaVincentius A Paulo Surabaya Hospital
Jan 8, 2022
Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Kohlmeier Degos Disease With Neurologic Involvement
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)
Not yet recruiting
- AML/MDS
- +2 more
- Danvatirsen
- Danvatirsen + Venetoclax
- (no location specified)
Aug 14, 2023
Immune Interactions in Severe Asthma
Recruiting
- Asthma
- 1 year Observational Follow-up
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Asthma Institute at UPMC
Mar 29, 2022
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Not yet recruiting
- Warts
- Detection of expression of SOCS3 gene
- +2 more
- (no location specified)
Mar 12, 2023
Marrow and Blood in Patients With Glioblastoma
Not yet recruiting
- Glioblastoma
- Biorepository
-
Durham, North CarolinaDuke University Medical Center
Jul 28, 2022
Alopecia Areata Trial in Assiut (Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin)
Not yet recruiting
- Alopecia Areata
- Betamethasone Valerate 0.1% Cream
- +2 more
-
Assiut, EgyptAssiut university
Oct 15, 2023
GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)
Terminated
- Graft Versus Host Disease
- +2 more
- Ruxolitinib 1.5% cream
- vehicle cream
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2022
Ulcerative Colitis Trial (Roflumilast 500 Ug ORAL TABLET [Daliresp], corticosteroids +immune suppressive +amino salicylic acid)
Not yet recruiting
- Ulcerative Colitis
- Roflumilast 500 Ug ORAL TABLET [Daliresp]
- corticosteroids +immune suppressive +amino salicylic acid
- (no location specified)
Jan 13, 2023
Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Trametinib
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 27, 2022
Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, Resectable Carcinoma Trial in Amsterdam (Tocilizumab 20 Mg/mL Intravenous
Active, not recruiting
- Esophageal Adenocarcinoma
- +2 more
- Tocilizumab 20 Mg/mL Intravenous Solution
- +3 more
-
Amsterdam, NetherlandsAcademic Medical Center, Medical Oncology
Dec 15, 2022
Human Papillomavirus-Related Malignant Tumor Trial in Wuhan (T512)
Recruiting
- Human Papillomavirus-Related Malignant Neoplasm
- T512
-
Wuhan, Hubei, ChinaTongji Hospital
Dec 29, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Brain Metastases, Adult Trial in Rozzano (Silibinin)
Recruiting
- Brain Metastases, Adult
- Silibinin
-
Rozzano, Milano, ItalyIRCCS Humanitas Research Hospital
Mar 20, 2023
Cancer, Metastasis, Metastatic Cancer Trial in Miami (Azeliragon, Stereotactic radiosurgery, Corticosteroid)
Not yet recruiting
- Cancer
- +4 more
- Azeliragon
- +2 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Mar 16, 2023